Page last updated: 2024-10-23

diminazene and Benign Neoplasms

diminazene has been researched along with Benign Neoplasms in 2 studies

Diminazene: An effective trypanocidal agent.
diminazene : A triazene derivative that is triazene in which each of the terminal nitrogens is substituted by a 4-carbamimidoylphenyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huang, TL1
Mayence, A1
Vanden Eynde, JJ1
Qaradakhi, T1
Gadanec, LK1
McSweeney, KR1
Tacey, A1
Apostolopoulos, V1
Levinger, I1
Rimarova, K1
Egom, EE1
Rodrigo, L1
Kruzliak, P1
Kubatka, P1
Zulli, A1

Reviews

2 reviews available for diminazene and Benign Neoplasms

ArticleYear
Some non-conventional biomolecular targets for diamidines. A short survey.
    Bioorganic & medicinal chemistry, 2014, Apr-01, Volume: 22, Issue:7

    Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myot

2014
The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
    Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:5

    Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Diminazene; Enzyme Activation; En

2020